FactorPad
Build a Better Process

Stock Risk Measures for Dicerna Pharmaceuticals Inc

A quantitative factor review, as of October 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: November 02, 2020
See how we arrive at an overall risk score of 60 for DRNA below.

/ factorpad.com / stocks / f45jvx.html


An ad-free and cookie-free webpage by FactorPad


DRNA Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Dicerna Pharmaceuticals Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how DRNA stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Biotechnology industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson and John J. Rossi in 2007 and is headquartered in Watertown, MA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f45jvx.html


DRNA stock risk
DICERNA PHARMACEUTICALS INC stock beta
DRNA risk report
DRNA f45jvx
DRNA risk analysis
DRNA volatility
DICERNA PHARMACEUTICALS INC credit risk
DRNA liquidity risk
DRNA leverage
DRNA valuation
DRNA systematic risk
DRNA specific risk
DICERNA PHARMACEUTICALS INC volatility
DRNA analysis
DRNA financial ratio

This is a new resource, spread the word, tell a friend